版本:
中国

BRIEF-Egalet announces results of ARYMO ER harm reduction modeling analysis

May 18 Egalet Corp

* Egalet announces results of ARYMO ER harm reduction modeling analysis

* Results suggest replacement of non-abuse-deterrent, extended-release morphine with ARYMO ER could lead to reductions in opioid abuse-related events Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐